GS

Leg	Exchange	Price	Fund. /8h	Each payment	Next in	OI	Vol 24h	Lev
LONG	InjectiveGS/USDC PERP	904.33	+0.0220	pay 0.0028% / 1h	32m 18s	$10K	$58K	10x	Long Injective
SHORT	BloFinGS-USDT	908.70	+0.0019	get 0.0019% / 8h	6h 32m	$88K	$55K	20x	Short BloFin

Price gap+0.483%

Funding gap−0.0201% /8h

The gap pays +$48 on $10k if it goes back to zero (no 7-day history yet), but funding costs $6 a day and eats that in about 8.0 days.

If you open now and hold

on $10k a leg · figures of the last 7D, not a forecast

Funding—−0.0201% /8h now · no funding history yet

Price—spread +0.483% now · no price history on both exchanges yet

Costsno datano order book for Injective and BloFin

Result, before costs—no pointsneeds funding history

Price and funding

1h · loading 5m…

Entry / ExitInjective: thin, under $1M open interest · BloFin: thin, under $1M open interest

Price spread

Prices

Fundingper 8h

ENTRY / EXIT · 7D

Entry now—

Entry average—

Best entry—

Exit now—

Exit average—

Best exit—

Exit free—

PRICE SPREAD · 7D

Now+0.483%

Average—

Range—

Wider than now—

FUNDING SPREAD · 7D

Average /8h—

Highest—

Lowest—

Paid you—

Where the spread has been, last 7D

share of time at each level

Funding on every exchange

/8h

GS on 11 exchanges

lowest funding first

Before you open

0 ok · 3 to watch

Note: Order book unknown—
No order-book sample for Injective and BloFin: its slippage is not counted.
Note: Margin at max leverage$1,000 + $500
Injective 10x, BloFin 20x. Keep about 2× this so a sharp move doesn’t liquidate one leg.
Watch: Payment intervals differ1h / 8h
Payments land at different times. Close right after the slower leg pays.
Next 24h at the current rates, on $10k a leg: −$6.02Long Injective: 24 payments, −$6.60; short BloFin: 3 payments, +$0.58.
Note: No 7-day spread history+0.483%
The gap cannot be compared with its average yet.
Watch: Long leg is thinner$10K vs $88K OI
Injective sets your exit cost. Check its book before closing.
Note: No points program—
Neither exchange runs points right now.
Watch: KYCInjective No · BloFin Limited
No ID to trade futures, with no leverage limit, but withdrawals are capped at 20,000 USDT a day until you verify.

Profit calculator

both legs, in and out

Position, each leg

Hold for

Orders

Price spread

Funding rate

Funding earnedno history yet: current rate−$42.12

Price spread+0.483% → 0+$48.28

Slippage, 4 ordersno data for Injective and BloFin—

Fee Injective bp × 2 orders−$0.02

Fee BloFin bp × 2 orders−$12.00

Net, fees only · 7 days · $10k−$5.86

Costs to cover0.120%Break-evenfrom the start

Slippage: Injective: no order-book sample; BloFin: no order-book sample

Cost to enter

taker + slippage from mid, one side

BUY · LONGInjective—————

SELL · SHORTBloFin—————

Closing costs about the same again.
Injective and BloFin: no data.

GS news

posts that mention GS or Goldman Sachs, from every exchangeSearch all news →

09-30 07:06	BloFin	Listing	BloFin Futures will list the $UNH-USDT, $KLAC-USDT, $SNOW-USDT, $GS-USDT, $HIMS-USDT, and $TMF-USDT Perpetual Contracts 🔥 Trade and take advantage of: ✅ 0% Maker Fees ✅ 50% off Taker Fees Details: @BloFin_Official on X ↗
09-30 02:40	BloFin	Listing	new market GS-USDT ($GS) seen by our collector
09-27 12:00	KuCoin	Other	AI has broken traditional stock valuation—some firms trade at under 2x earnings while posting 600%+ revenue growth, while others with steady cash flows sit at discounts that imply obsolescence. Goldman Sachs notes AI companies have added ~$27 trillion in market value since 2022, yet the estimated present value of future AI profits sits closer to $9 trillion—a gap investors are betting will close. Is the market pricing in AI's future, or getting ahead of itself? We break it all down on the KuCoin Blog 👇 @kucoincom on X ↗
09-22 13:13	Bitget	Other	Why OURA: 💍 74% global smart ring market share 📈 5M+ paid members 🏛️ Underwritten by Goldman Sachs, Morgan Stanley & JPMorgan 💰 Valuation range ~$156–160B No lock-ups, no queues. Go long or short pre-listing. @bitget on X ↗
09-20 14:35	Kalshi	Other	JUST IN: Goldman Sachs analysts say the SEC’s 'innovation exemption' could "benefit" Coinbase and Robinhood @Kalshi on X ↗

GS